Summary of price information for serputinib/serpatinib in 2025

Selpercatinib is a targeted therapy drug targeting RET gene mutations. It is mainly used to treat RET gene fusion-positive non-small cell lung cancer (NSCLC) and thyroid cancer with RET mutation-positive thyroid cancer. The launch of this drug provides a new treatment option for patients who carry RET gene alterations, especially when standard treatments fail to effectively control the disease, Seputinib has shown good efficacy. Studies have shown that seputinib can significantly improve disease control rates and patient survival in these specific patient groups.

In China, the original drug of seputinib has been officially launched, but it has not yet been included in the national medical insurance directory, which makes medical costs an important issue for patients. According to market information, Seputinib is priced at 80mg*56 capsules per box and is expected to sell for more than RMB 10,000. Although the price of the drug is relatively high in China, many patients are still willing to try this new drug considering its targeted therapeutic properties and effectiveness for specific patient groups.

In the international market, the price of seputinib also varies by region and pharmaceutical company. The selling price of overseasoriginal drugs is usually between 20,000 to more than 100,000 yuan. The specific price may change due to exchange rate fluctuations. In addition, with the continuous development of the drug market, some generic drugs of seputinib have appeared in overseas markets. Take the generic drugs produced by Lao pharmaceutical factories as an example. The specifications are 40mg*120 pills per box, and the price is about more than 2,000 yuan, which is also affected by the exchange rate.

Although the price of generic drugs is relatively low, patients need to carefully understand the quality and efficacy of the drugs when using them to ensure that they choose a treatment plan that meets their needs. At the same time, patients should consult professional physicians to obtain scientific and reasonable medication recommendations when seeking treatment.

Reference:https://en.wikipedia.org/wiki/Selpercatinib